Laura Vinuesa (@lauravinuesadvm) 's Twitter Profile
Laura Vinuesa

@lauravinuesadvm

DVM fascinated by #innovation. Senior Manager, Marketing Sciences @GileadSciences. Views R mine. Follow/RT ≠ endorsements.

ID: 3063815319

linkhttps://uk.linkedin.com/in/lauravinuesa calendar_today26-02-2015 10:07:19

1,1K Tweet

1,1K Takipçi

4,4K Takip Edilen

Nature Reviews Drug Discovery (@natrevdrugdisc) 's Twitter Profile Photo

The endometrial carcinoma market go.nature.com/3tMQXrH This new article by Laura Vinuesa and @RWebsterDRG analyses the pipeline of therapies for endometrial cancer and the market, which is expected to grow substantially in the next decade

The endometrial carcinoma market go.nature.com/3tMQXrH This new article by <a href="/LauraVinuesaDVM/">Laura Vinuesa</a> and @RWebsterDRG analyses the pipeline of therapies for endometrial cancer and the market, which is expected to grow substantially in the next decade
Axel S. Merseburger (@amerseburger) 's Twitter Profile Photo

For #worldcancerday2022 We Will Close the Care Gap‼️ “Cancer cannot cripple love, it cannot shatter hope, it cannot conquer the spirit" We are & We will #GU22 We are OncoAlert 🚨

For #worldcancerday2022 

We Will Close the Care Gap‼️

“Cancer cannot cripple love, it cannot shatter hope, it cannot conquer the spirit"

We are &amp; We will                 #GU22 
We are <a href="/OncoAlert/">OncoAlert</a> 🚨
Nazli Dizman (@nazlidizman) 's Twitter Profile Photo

🥁Thrilled to announce that our paper is out Nature Medicine! We looked at the impact of nivolumab/ipilimumab +/- #CBM588 a bifidogenic live bacterial product, on gut #Microbiome, serum cytokines & clinical outcomes in #mRCC 🙏🙏Sumanta K. Pal, MD, FASCO Luis A. Meza Paulo G Bergerot et al. 1/n🧵

🥁Thrilled to announce that our paper is out <a href="/NatureMedicine/">Nature Medicine</a>!

We looked at the impact of nivolumab/ipilimumab +/- #CBM588 a bifidogenic live bacterial product, on gut #Microbiome, serum cytokines &amp; clinical outcomes in #mRCC

🙏🙏<a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> <a href="/LuisMezaco/">Luis A. Meza</a> <a href="/PauloBergerot/">Paulo G Bergerot</a> et al.
1/n🧵
Dr Sunil Verma (@cancermd) 's Twitter Profile Photo

Inspiring and emotional day today as we watched the premiere of documentary on José Baselga–a titan in the field who transformed Cancer care.  He was a friend and inspired many in Oncology community. His legacy will live on through our work. Stream now: CancersFiercestOpponent.com

Inspiring and emotional day today as we watched the premiere of documentary on José Baselga–a titan in the field who transformed Cancer care.  He was a friend and inspired many in Oncology community. His legacy will live on through our work. Stream now: CancersFiercestOpponent.com
EFPIA (@efpia) 's Twitter Profile Photo

On #InternationalWomensDay, we celebrate the extraordinary contribution women are making to society, science and healthcare. #WeWontRest challenging biases and building a culture of inclusion and equal opportunities #BreakTheBias Nathalie Moll

On #InternationalWomensDay, we celebrate the extraordinary contribution women are making to society, science and healthcare. #WeWontRest challenging biases and building a culture of inclusion and equal opportunities #BreakTheBias 
<a href="/NathalieMoll/">Nathalie Moll</a>
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Great news finally!!! Today FDA Oncology approved Lutetium-177-PSMA-617 PLUVICTO for metastatic CRPC #ProstateCancer after prior ARAT/NHT and taxane. OncLive SOSS UroToday.com PCF Science Weblink 👉 bit.ly/3wxh07x

Great news finally!!! Today <a href="/FDAOncology/">FDA Oncology</a> approved Lutetium-177-PSMA-617 PLUVICTO for metastatic CRPC #ProstateCancer after prior ARAT/NHT and taxane. <a href="/OncLiveSOSS/">OncLive SOSS</a> <a href="/urotoday/">UroToday.com</a> <a href="/PCF_Science/">PCF Science</a> Weblink 👉 bit.ly/3wxh07x
Michael Hofman (@drmhofman) 's Twitter Profile Photo

Hot off the press. PSMA theranostics FDA approved: Lu-177 PSMA-617 (Pluvicto™) + Ga-68 kit (Locametz®) for PET imaging. First radioligand therapy for prostate cancer. Peter Mac Cancer Centre ph2 spearheaded development. Prolongs survival & Improves quality of life globenewswire.com/news-release/2…

Laura Vinuesa (@lauravinuesadvm) 's Twitter Profile Photo

It's #goodforbusiness to protect the environment! Join me in advocating for the #TenPrinciples of the UN Global Compact and the #GlobalGoals. #UnitingBusiness #Environment unitingbusiness.zone/p/iefdf8Qic?r=…

WHO/Europe (@who_europe) 's Twitter Profile Photo

Today is #WorldHealthDay! Working together we can build a #HealthierTomorrow – for people & planet 🌍 Want to get started? Check out the tips below 👇 1/7

Today is #WorldHealthDay! 

Working together we can build a #HealthierTomorrow – for people &amp; planet 🌍

Want to get started? Check out the tips below 👇

1/7
EFPIA (@efpia) 's Twitter Profile Photo

One-off, curative therapies are replacing a life time of care but also pose challenges for healthcare systems: novel pricing and payment models could facilitate patient access and balance the sustainability of the healthcare system. Read more: bit.ly/3JeJNka #WeWontRest

EFPIA (@efpia) 's Twitter Profile Photo

Improving transparency on the root causes of unavailability and delay is key to finding solutions. Find out more on our new portal to collect info of pricing & reimbursement applications in the EU-27 ➡️ bit.ly/3r8R1zT #WeWontRest

Clarivate (@clarivate) 's Twitter Profile Photo

🌎 2021 Sustainability Report >> We’ve integrated #sustainability & #ESG into everything we do at Clarivate. Discover our strategy, goals and accomplishments in our latest report. Download now: clarivate.com/sustainability… #SustainabilityatClarivate

🌎 2021 Sustainability Report &gt;&gt; We’ve integrated #sustainability &amp; #ESG into everything we do at Clarivate. Discover our strategy, goals and accomplishments in our latest report.  

Download now: clarivate.com/sustainability…

#SustainabilityatClarivate
ISPOR (@ispororg) 's Twitter Profile Photo

The Digital Health Special Interest Group published a new paper, titled “How Useful Are Digital Health Terms for Outcomes Research? An ISPOR Special Interest Group Report” in the September issue of Value in Health. To read the article, click here: ow.ly/NSEh50Kxay6

The Digital Health Special Interest Group published a new paper, titled “How Useful Are Digital Health Terms for Outcomes Research? An ISPOR Special Interest Group Report” in the September issue of Value in Health. To read the article, click here: ow.ly/NSEh50Kxay6
Laura Vinuesa (@lauravinuesadvm) 's Twitter Profile Photo

Donate to my fundraising page and help raise life-saving funds for Cancer Research UK fundraise.cancerresearchuk.org/page/lauras-gi…